Literature DB >> 18433343

Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies.

Dora Farkas1, David J Greenblatt.   

Abstract

BACKGROUND: Grapefruit juice is known to alter the pharmacokinetics of over 30 prescription drugs by increasing their bioavailabilities. After the discovery of this interaction almost 20 years ago, there have been many reports investigating the effects of fruit juices on drug disposition.
OBJECTIVE: This article reviews the literature on fruit juice-prescription drug interaction studies to determine which juices are likely to cause clinically significant interactions.
METHODS: We examined the results from in vitro and clinical studies regarding the interactions between prescription drugs and over ten fruit beverages. RESULTS/
CONCLUSIONS: Grapefruit juice and Seville orange juice caused several clinically significant interactions with cytochrome P4503A (CYP3A). The OATP drug transporter was inhibited by grapefruit juice, orange juice, and apple juice. Other fruit juices also interacted with drug metabolizing enzymes and transporters in vitro, but more studies are needed to determine whether these interactions are clinically significant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433343     DOI: 10.1517/17425255.4.4.381

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  16 in total

Review 1.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 2.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 3.  Cancer chemotherapy: with or without food?

Authors:  Aminah Jatoi
Journal:  Support Care Cancer       Date:  2009-06-01       Impact factor: 3.603

4.  Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects.

Authors:  Kentarou Ushijima; Shu-ichi Tsuruoka; Hidetoshi Tsuda; Gohki Hasegawa; Yuri Obi; Tae Kaneda; Masaki Takahashi; Tomohiro Maekawa; Tomohiro Sasaki; Taka-aki Koshimizu; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

5.  Pharmacokinetics of linagliptin in subjects with hepatic impairment.

Authors:  Ulrike Graefe-Mody; Peter Rose; Silke Retlich; Arne Ring; Lisa Waldhauser; Rodica Cinca; Hans-Juergen Woerle
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 6.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

7.  Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily.

Authors:  Patrick Reddy; David Ellington; Yiliang Zhu; Immo Zdrojewski; Sarah J Parent; Jerold S Harmatz; Hartmut Derendorf; David J Greenblatt; Kevin Browne
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 8.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

9.  Pomegranate juice and pomegranate extract do not impair oral clearance of flurbiprofen in human volunteers: divergence from in vitro results.

Authors:  M J Hanley; G Masse; J S Harmatz; M H Court; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

10.  Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.

Authors:  Ngoc Ngo; Zhixia Yan; Tyler N Graf; Daniel R Carrizosa; Angela D M Kashuba; E Claire Dees; Nicholas H Oberlies; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2008-12-29       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.